宜宾双眼皮没割好图片(宜宾整形医院割双眼皮的价钱) (今日更新中)

SAN DIEGO (KGTV) — A man was arrested on battery and hate crime charges Thursday after he punched a man who recently arrived from Afghanistan and threatened to kill his family.San Diego Police said Robert Compton, 48, was on a trolley in the Grantville area on Feb. 26 just before 12 p.m., when he approached a family of four who recently moved to San Diego from Afghanistan. The family was being given a tour from a Catholic charity helping them during their transition to the area.Police say Compton told the 41-year-old father and threatened to kill the family. He also told the family to "go back to where you came from, I hate you," according to SDPD.RELATED:News conference turns into confrontation over "smart streetlights"Man gets five years for Trolley hate crime attack on Syrian refugeeCompton then punched the man, causing multiple fractures to his face, and fled the trolley.Police responded and began investigating the assault as a hate crime. Compton was identified as a suspect using information obtained from the city's smart streetlights and arrested at 800 Market Street.The data from the smart streetlight also placed Compton as the suspect of another unprovoked felony battery that occurred two days later, though that assault is not believed to be hate motivated."Our department does not tolerate violent acts motivated by hate and will investigate all incidents to ensure the safety of all members of our community," SDPD said in a release.Smart streetlights have been a hotly debated enforcement tool in San Diego, with critics raising privacy concerns and lack of oversight. 1608

(AP) - With CBD showing up everywhere, U.S. regulators announced Tuesday they are exploring ways the marijuana extract could be used legally in foods, dietary supplements and cosmetics.The U.S. Food and Drug Administration said it will hold a public hearing May 31 to gather more information on the science, manufacturing and sale of cannabis compounds like CBD.In the meantime, it issued more warning letters to companies for making unapproved health claims about CBD products.Products containing CBD are already in stores and sold online, so it's easy to believe there must be something special about the ingredient. But the claims are largely unproven and quality control standards don't exist.RELATED: Can using CBD products cost someone their job? A look at what we know as U.S. regulators work out what will and won't be allowed:WHAT IS CBD?CBD is one of more than 100 compounds found in marijuana. It's extracted using alcohol or carbon dioxide in factories. It's added to oils, mixed into creams and lotions and sold in candies and liquid drops.Widely sold online, CBD now is going mainstream with major retailers offering salves and balms for the skin. Prices range from to 0 an ounce at high-end shops.CBD often comes from a cannabis plant known as hemp, which is defined by the U.S. government as having less than 0.3 percent THC. That's important because THC is what causes marijuana's mind-altering effect.CBD doesn't get people high, although it may be calming. Keep in mind some CBD products may contain THC, whether or not the label says so.RELATED: CBD-infused foods become rising trend in 2019People drug tested for work, addiction programs or because they take prescription opioids should take note: CBD products have caused people to fail urine drug screens.IS IT A MIRACLE CURE?If you believe the hype, CBD treats pain, relieves anxiety and both helps you sleep and keeps you focused.Most claims are based on studies in rats, mice or in test tubes. Some human research has been done, but in small numbers of people.One exception: For two rare seizure disorders, the evidence for CBD was strong enough to convince the FDA to approve GW Pharmaceutical's drug Epidiolex, which contains a purified form.The FDA announced Tuesday it has sent warning letters to three companies marketing products with what outgoing Commissioner Scott Gottlieb called "egregious, over-the-line claims" for CBD's effects on cancer, Alzheimer's disease, fibromyalgia and drug addiction. Gottlieb said the agency "won't tolerate this kind of deceptive marketing to vulnerable patients."RELATED: CVS Pharmacy selling cannabis-based products in stores in California, 7 other statesOnly drugs that have been reviewed by the FDA as safe and effective can make claims that they treat or prevent diseases or medical conditions. Many CBD producers attempt to sidestep the issue by using only vague language about general health and well-being.ANY SIDE EFFECTS?Scant research means not much is known about side effects either. In epilepsy research, CBD changed the way the body processed other drugs. That suggests CBD could interact with medications in ways we still don't know about.The most common side effects of the CBD drug Epidiolex include sleepiness, decreased appetite, diarrhea, increases in liver enzymes, exhaustion, rash and infections. FDA's Gottlieb noted Tuesday the potential for liver injury and other risks can be handled with medical supervision but less is known about how that would be managed without oversight. And there are questions about overlap if multiple CBD products are used.IS IT LEGAL?For now, the agency has said CBD is not allowed as an ingredient in food, drinks or dietary supplements.In stating its position, the FDA cited a provision of the law prohibiting food makers from using active drug ingredients or those that are the subject of substantial research. But the agency doesn't have the resources to police all the CBD products that are already available, said Marc Scheineson, a former FDA official.RELATED: Creator of Jelly Belly releases CBD-infused jelly beans"They're not going to pull a thousand products from the market," he said.The FDA's authority is over interstate commerce, and local officials have taken differing approaches. In New York, Los Angeles and elsewhere, officials are warning eateries to stop selling it in food and drinks. Maine passed a law allowing it in foods and other products in the state.Skin creams and cosmetics may be on safer footing with the FDA, but that too remains uncertain, said Camille Gourdet of RTI International, a nonprofit research institute in Durham, North Carolina. Though cosmetics aren't subject to premarket approval by the FDA, they could run afoul of regulations if they make specific health claims.Marijuana itself is illegal under federal law; most states that have legalized it allow marijuana-infused foods and candies, called edibles.ARE CBD LABELS ACCURATE?What you buy may contain much less CBD than the label states — or much more. It may include more THC than you want and it may be contaminated with mold or pesticides. Ask to see testing reports.A 2017 study in the Journal of the American Medical Association found 70 percent of CBD products were mislabeled. Researchers used an independent lab to test 84 products from 31 companies."You're really flying by the seat of your pants when you buy this stuff," said author Marcel Bonn-Miller of University of Pennsylvania.A product labeled as containing 100 milligrams of CBD may only have 5 milligrams or it may have 200, said Bonn-Miller, now an adviser for a company that sells CBD and other cannabis products. He did not work in the industry when he did the research."I wouldn't trust any of it until I knew independently it was safe," Bonn-Miller said.WHAT'S AHEAD?CBD research is planned or underway for cancer, autism, diabetic neuropathy, fibromyalgia, chronic pain, alcoholism with PTSD and psychiatric conditions. Results will take years, but some people aren't waiting."They are vulnerable and really hoping to feel better," said Karen Hande, a nurse practitioner at Vanderbilt-Ingram Cancer Center in Nashville.She became an expert in CBD because so many of her cancer patients were trying it. She tells them the evidence isn't enough to back the claims, but "they want to believe something is going to work." 6383

With the Food and Drug Administration (FDA) yet to develop a regulatory framework for CBD-infused products, states are stepping in. This week, Illinois introduced new legislation that could require the testing of CBD products sold in its state. The hemp-derived cannabidiol, or CBD, is sold as a supplement, promising to manage everything from anxiety and insomnia to chronic pain.Rahul Easwar, co-founder of Chicago-based CBD-retailer LeafyQuick, says the product is everywhere.“Gummies, edibles, we’ve got bath bombs, salts, topical lotions," Easwar says. "You name it, there’s CBD in it.”But while some CBD shops like LeafyQuick only sell products that have been tested, there are no laws requiring that. “We don’t obviously accept every brand that knocks on our door, and we go through a very stringent due-diligence process,” says Easwar.And because CBD products are considered supplements rather than drugs, they remain largely unregulated. Since 2015 the Food and Drug Administration has issued more than four dozen warning letters to firms marketing unapproved drugs allegedly containing CBD. Many did not contain the levels of the cannabis derivative they claimed to.It’s that uncertainty about what’s in the products that prompted Illinois state representative Bob Morgan to act. “These are products coming in from other states more often than not are not being tested,” says Morgan. “We don't know if they have heavy metals pesticides contaminants synthetic THC or something way worse.”Morgan is pushing a bill that would require all CBD products sold in the state to pass minimum testing standards. “We should have these high expectations, especially since people were consuming this product,” says Morgan. “These are things people are ingesting and we have to make sure they’re safe.”If they’re not safe, the proposed law would require untested products to be pulled from shelves and online. Sellers violating the law could face stiff fines.It’s something retailers like Rahul Easwar say is essential to the CBD business' long-term success.“Especially retailers, more so the consumers need to demand such regulations and more stringent regulations in my opinion.”For now, there are still no national standards for CBD testing. Morgan says until federal regulators catch it’s up to the states to take the lead. 2334

(AP) - LeBron James went to the NBA Finals for the eighth consecutive year. He changed addresses again, leaving his Cleveland home for the second time to join the Los Angeles Lakers in the biggest move of free agency over the summer. He remained arguably the dominant player in the basketball, adding even more glitz on a legacy that reached epic status long ago.It was, by any measure, a fantastic year for James.And even without a title, it may have been his most significant year.For the third time, James has been selected as The Associated Press Male Athlete of the Year — after 2018 saw him continue to excel on the court, open the "I Promise" school for at-risk children in his hometown of Akron, Ohio, and further use his voice as an activist who bristled at being told to "shut up and dribble.""I would describe it as a success because I was able to inspire so many people throughout the year," James said. "I got to go back to China, to Paris, to Berlin, I opened up a school. And all these kids I was able to see, all over the world and in my hometown, I was able to inspire, to make them think they can be so much more than what they think they're capable of being. That was my outlook for 2018."James received 78 points in balloting by U.S. editors and news directors announced Thursday, while Boston Red Sox star Mookie Betts was second with 46. Alex Ovechkin of the Washington Capitals was third, Kansas City Chiefs quarterback Patrick Mahomes was fourth and Triple Crown winner Justify was fifth.On the court, James remained dominant. He averaged 28.7 points, 8.8 rebounds and 8.4 assists in 2018 between his time with the Cavaliers and Lakers, playing in 102 games through Thursday."In addition to being on everyone's short list as one of the league's all-time greatest players, LeBron is among the hardest working players and is a thoughtful and impactful leader," NBA Commissioner Adam Silver said. "He serves on the executive committee of the Players Association even as he builds an impressive media company of his own. And what's most inspiring, and no surprise given his talent and focus, is how he's done all of this while embracing his unique opportunity to positively impact communities in need."James becomes the third man to win the award at least three times, joining Lance Armstrong (a four-time winner from 2002 through 2005), Tiger Woods (1997, 1999, 2000 and 2006) and Michael Jordan (1991, 1992 and 1993).Armstrong won the Tour de France in each of his years as the AP recipient, — though he was later stripped of the titles in a doping scandal. Woods won at least one major and was the PGA's Player of the Year in all four of his AP-winning years. Jordan's three awards coincided with his first three NBA championships in Chicago. And James' first two times getting the award were in 2013 and 2016, years where his fingerprints mussed up the Larry O'Brien Trophy in a title celebration.And James' closest rivals in the AP balloting this year — Betts and Ovechkin — also won titles in 2018.James' year included no championship, no scoring title, no MVP award. But some of the people closest to James still considered 2018 to be his finest year yet."I like to talk about generations," said Miami guard Dwyane Wade, one of James' best friends. "There will never be another Michael Jordan because he was the first to be a global superstar, the first to take the NBA to another level. There will never be another LeBron James, and a lot of it is from what he's done away from the game. Him understanding his voice has been so refreshing and so important to the culture and his friends."The "I Promise" school is perhaps James' most prized accomplishment yet. It opened in July for 240 third- and fourth-graders, a public school in Akron that is perhaps like none other. Families — not just the kids — get support there, whether it's by helping put food on the table or providing adult education or even legal assistance.And this is just the start. James and his LeBron James Family Foundation have enormous plans for the school in the years ahead."It is already such a success," James said. "And it's something that I never thought was possible until we made it happen. So yes, it's been a pretty good year."A busy year, too.He had a documentary series called "Shut Up and Dribble," which discusses the role athletes have in the current political and cultural climate. His show "The Shop," featuring James and friends talking about life in the backdrop of a barbershop, has been enormously popular. James has faced criticism in recent days for posting rap lyrics that included the phrase "Jewish money," for which he apologized, and even rival coaches have spoken out about how he's used his fame for good."To this day, he hasn't missed a step," San Antonio coach Gregg Popovich said earlier this year. "He hasn't fallen off the ledge and he's been a brilliant example for millions of kids, especially kids with lesser opportunity and haven't had the same advantages as others."On the court, he was already an icon.Off the court, he's looking to be one as well in the years ahead."The next star is out there," James said. "And I'm not just talking sports. Doctor, nurse, pilots, they're out there. The one thing they need is knowing that people care about them and care about their lives. I believe it's part of my job, and I take it very seriously, to try to tap into that." 5413

(AP) — It could be a landmark election year for the legal marijuana industry. Voters in four states could approve broad legal marijuana sales, as the push for legalization continues across the US. The contests will take place in vastly different regions — New Jersey, Arizona, South Dakota and Montana. If approved in a sweep, it would highlight how public acceptance of cannabis is cutting through geography, demographics and politics. The most closely watched race is New Jersey, which if approved could prompt New York, Pennsylvania and other Northeast states to follow. Meanwhile, voters in conservative Mississippi will consider competing proposals that would legalize medicinal marijuana. 702

来源：资阳报